Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F20%3AA21025ZB" target="_blank" >RIV/61988987:17110/20:A21025ZB - isvavai.cz</a>
Alternative codes found
RIV/27661989:_____/20:N0000005
Result on the web
<a href="https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.23427" target="_blank" >https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.23427</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/jcla.23427" target="_blank" >10.1002/jcla.23427</a>

Result language
angličtina
Original language name
Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation
Original language description
Patients taking digoxin are older with high probability of having low muscle mass, and current clinical practice in digoxin dosing relies only on estimated glomerular filtration rate from serum creatinine (eGFRcrea). The aim of the study is to compare eGFRcrea and estimated glomerular filtration rate from serum cystatin C (eGFRcys) in older adult patients with atrial fibrillation (AF) overdosed with digoxin.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
20602 - Medical laboratory technology (including laboratory samples analysis; diagnostic technologies) (Biomaterials to be 2.9 [physical characteristics of living material as related to medical implants, devices, sensors])

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)